• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 3

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Gratitude Revealed: Film Screening and Q&A with Director Louie Schwartzberg

Sunstone Therapies Announces Expansion of Innovative Dyad Study

PT447 – Exile & Ecstasy: The Intersection of Jewish Culture, Spirituality, and Psychedelics

Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical Research

atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants

Bridging Dimensions: Understanding the Mystical Experience

PT443 – Swimming in the Sacred: The Wisdom of Underground Female...

Psychedelic Bulletin #145: MAPS’ Second Phase 3 Study Published; EMA’s New...

Numinus Congratulates MAPS on its Phase 3 Study Results Published in...

Numinus Takes Actions to Accelerate its Path to Profitability by Focusing...

COMPASS Pathways appoints Daphne Karydas to its Board of Directors

Clearmind Medicine Closes US$2.25 Million Public Offering

Reunion Neuroscience Inc. Announces FDA Clearance of IND Application to Initiate...

PT442 – Burning Questions About Burning Man: Mud, Ebola, and the...

Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted...

1234...237Page 3 of 237

EDITOR PICKS

Gratitude Revealed: Film Screening and Q&A with Director Louie Schwartzberg

Sunstone Therapies Announces Expansion of Innovative Dyad Study

PT447 – Exile & Ecstasy: The Intersection of Jewish Culture, Spirituality,...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©